Literature DB >> 23500060

On the efficacy of malaria DNA vaccination with magnetic gene vectors.

Fatin Nawwab Al-Deen1, Charles Ma, Sue D Xiang, Cordelia Selomulya, Magdalena Plebanski, Ross L Coppel.   

Abstract

We investigated the efficacy and types of immune responses from plasmid malaria DNA vaccine encoding VR1020-PyMSP119 condensed on the surface of polyethyleneimine (PEI)-coated SPIONs. In vivo mouse studies were done firstly to determine the optimum magnetic vector composition, and then to observe immune responses elicited when magnetic vectors were introduced via different administration routes. Higher serum antibody titers against PyMSP119 were observed with intraperitoneal and intramuscular injections than subcutaneous and intradermal injections. Robust IgG2a and IgG1 responses were observed for intraperitoneal administration, which could be due to the physiology of peritoneum as a major reservoir of macrophages and dendritic cells. Heterologous DNA prime followed by single protein boost vaccination regime also enhanced IgG2a, IgG1, and IgG2b responses, indicating the induction of appropriate memory immunity that can be elicited by protein on recall. These outcomes support the possibility to design superparamagnetic nanoparticle-based DNA vaccines to optimally evoke desired antibody responses, useful for a variety of diseases including malaria.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500060     DOI: 10.1016/j.jconrel.2013.02.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.

Authors:  Dhirender Singh; JoEllyn M McMillan; Xin-Ming Liu; Hemant M Vishwasrao; Alexander V Kabanov; Marina Sokolsky-Papkov; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2014-03-19       Impact factor: 5.307

Review 2.  Influential Factors and Synergies for Radiation-Gene Therapy on Cancer.

Authors:  Mei Lin; Junxing Huang; Yujuan Shi; Yanhong Xiao; Ting Guo
Journal:  Anal Cell Pathol (Amst)       Date:  2015-12-09       Impact factor: 2.916

3.  Self-Assembly DNA Polyplex Vaccine inside Dissolving Microneedles for High-Potency Intradermal Vaccination.

Authors:  Jing-Fong Liao; Jin-Ching Lee; Chun-Kuang Lin; Kuo-Chen Wei; Pin-Yuan Chen; Hung-Wei Yang
Journal:  Theranostics       Date:  2017-06-25       Impact factor: 11.556

4.  Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines.

Authors:  Fatin M Nawwab Al-Deen; Sue D Xiang; Charles Ma; Kirsty Wilson; Ross L Coppel; Cordelia Selomulya; Magdalena Plebanski
Journal:  Nanomaterials (Basel)       Date:  2017-02-10       Impact factor: 5.076

Review 5.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29

Review 6.  Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies.

Authors:  Michael Lim; Abu Zayed Md Badruddoza; Jannatul Firdous; Mohammad Azad; Adnan Mannan; Taslim Ahmed Al-Hilal; Chong-Su Cho; Mohammad Ariful Islam
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.